While postmenopausal women have an increased risk of developing ERα+ luminal breast cancers [24–26], both premenopausal and postmenopausal obese women also have an increased likelihood of being diagnosed with ERα- tumors compared with lean women [29, 30]. This evidence concerns the gene ESR1 and breast carcinoma.